William H. Shrank, MD, MSHS

Our research focuses on the clinical and economic outcomes of patients receiving care from a payer-designated specialty pharmacy program compared with regular retail pharmacies.

Efforts to compare strategies for healthcare delivery must evaluate effectiveness in terms of the outcomes that we care about most.

The greater use of generic prescription medications has been widely advocated as a policy solution to rising healthcare costs.

P&T committees should implement more rigorous formulary restrictions that stimulate manufacturers to meet a higher standard when bringing new therapies to market.